The body's growth hormone system operates through a carefully regulated feedback loop. The hypothalamus releases GHRH (growth hormone-releasing hormone) in pulses, which signals the pituitary to release GH into the bloodstream. GH then stimulates the liver to produce IGF-1, which carries out most of GH's tissue-building effects.
GH secretagogue peptides mimic and amplify this natural cascade. CJC-1295 is a long-acting GHRH analog. It extends the natural GHRH pulse. Ipamorelin is a ghrelin receptor agonist. It provides a second, complementary signal to the pituitary. Together they produce GH releases 3–5x higher than baseline while preserving the natural pulsatile pattern.
The CJC-1295 + Ipamorelin combination is the most commonly prescribed GH peptide stack because it uses two different receptor mechanisms simultaneously, like pushing two accelerator pedals at once, for synergistic GH release that far exceeds either peptide alone.
Unlike direct HGH injection, secretagogue peptides allow the pituitary's feedback systems to remain intact. If GH levels rise too high, the body's natural inhibitory mechanisms engage. This built-in safety feature makes secretagogues the preferred approach for most patients.
